Cargando…

Checkpoint blockade therapy for functioning pituitary adenomas

Detalles Bibliográficos
Autores principales:	Lorrey, Selena J., Kemeny, Hanna R., Fecci, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343575/ https://www.ncbi.nlm.nih.gov/pubmed/32676516 http://dx.doi.org/10.18632/oncoscience.509

Ejemplares similares

SYST-05 BETA-ADRENERGIC BLOCKADE LICENSES THE USE OF IMMUNOTHERAPY IN PRIMARY AND METASTATIC BRAIN TUMORS
por: Lorrey, Selena, et al.
Publicado: (2023)

4-1BB Agonism as a strategy to license immune checkpoint blockade in glioblastoma
por: Woroniecka, Karolina, et al.
Publicado: (2020)

BSCI-07. BONE MARROW T-CELL SEQUESTRATION IN THE SETTING OF BRAIN METASTASES
por: Chongsathidkiet, Pakawat, et al.
Publicado: (2019)

HSP90 as an emerging barrier to immune checkpoint blockade therapy
por: Tang, Daolin, et al.
Publicado: (2022)

Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
por: Tsuji, Ai, et al.
Publicado: (2023)

BSBM-19 CROSS-PRESENTATION BY TUMOR-ASSOCIATED MACROPHAGES MEDIATES THE TRANSITION FROM PROGENITOR TO TERMINAL T CELL EXHAUSTION IN PRIMARY AND METASTATIC BRAIN TUMORS
por: Polania, Jessica Waibl, et al.
Publicado: (2023)

Epidemiology of Functioning Pituitary Adenomas
por: Chin, Sang Ouk
Publicado: (2020)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Immune suppression in gliomas
por: Grabowski, Matthew M., et al.
Publicado: (2020)

CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
por: Miggelbrink, Alexandra M., et al.
Publicado: (2021)

Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
por: Tan, Shuguang, et al.
Publicado: (2016)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)

Current and Future Advances in Surgical Therapy for Pituitary Adenoma
por: Khan, Danyal Z, et al.
Publicado: (2023)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Cytology of Pituitary Adenomas
por: Doniach, I.
Publicado: (1972)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

The Genetics of Pituitary Adenomas
por: Tatsi, Christina, et al.
Publicado: (2019)

Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Pseudoacromegaly Associated with Non-Functioning Pituitary Adenoma
por: Alotaibi, Awatef, et al.
Publicado: (2020)

Medical Management of Functioning Pituitary Adenoma: An Update
por: OKI, Yutaka
Publicado: (2014)

Mortality in patients with non-functioning pituitary adenoma
por: Tampourlou, Metaxia, et al.
Publicado: (2018)

Clinically Functioning FSH-Secreting Pituitary Adenoma
por: AlNasrallah, Noor, et al.
Publicado: (2021)

Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Dai, Congxin, et al.
Publicado: (2021)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
por: Miermeister, Christian P., et al.
Publicado: (2015)

Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
por: Esposito, Daniela, et al.
Publicado: (2019)

Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly
por: Wormhoudt, Tiffany L., et al.
Publicado: (2018)

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
por: Tomaszewski, William H., et al.
Publicado: (2022)

Refractory pituitary adenoma: a novel classification for pituitary tumors
por: Dai, Congxin, et al.
Publicado: (2016)

Potential biomarkers of miRNA in non-functional pituitary adenomas
por: Zhang, Qizhi, et al.
Publicado: (2021)

Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020)

Collision Tumor in the Pituitary, Concurrent Pituitary Adenoma, and Craniopharyngioma
por: Shareef, Zaid, et al.
Publicado: (2020)

The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020)

Primary pituitary tubercular abscess mimicking as pituitary adenoma
por: Ranjan, Rakesh, et al.
Publicado: (2011)

Seeding of a Pituitary Adenoma or Atypical Pituitary Carcinoma?
por: Krueger, Evan M, et al.
Publicado: (2017)

Pathology of the human pituitary adenomas
por: Osamura, Robert Y., et al.
Publicado: (2008)

Pituitary adenomas: a review
por: Sharif-Alhoseini, Mahdi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ols0ji3uod95v5tuscsq9c5jbo